Revolna Therapeutics is developing a novel RNA platform that will have the following key attributes:
High Protein Expression
High Expression Duration
High Stability
Low Needed Dosing
This novel, proprietary RNA platform enables potent, long-lasting, and highly stable therapeutics that are both effective and accessible.